<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03566732</url>
  </required_header>
  <id_info>
    <org_study_id>ELAC2015/T07-0545</org_study_id>
    <nct_id>NCT03566732</nct_id>
  </id_info>
  <brief_title>ERANet-LAC CODE: International Care Of the Dying Evaluation</brief_title>
  <official_title>International Care Of the Dying Evaluation (CODE): Quality of Care for Cancer Patients as Perceived by Bereaved Relatives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sue Ryder House administered by Pallmed</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mutualista Asociación Hospital Evangélico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pallium Latinoamérica N.G.O</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Mainz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Liverpool</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bergen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Providing high quality care for dying patients and their families is very important. One way&#xD;
      one can assess the care provided is to ask bereaved relatives to complete a questionnaire&#xD;
      after their family member has died. The questionnaire can ask about their experiences and&#xD;
      their thoughts about the care provided to their family member.&#xD;
&#xD;
      One such questionnaire is the 'Care Of the Dying Evaluation' (or CODE). CODE has been&#xD;
      developed with the help and support of bereaved relatives and has been used extensively&#xD;
      within the United Kingdom. In this project the investigators want to use the CODE&#xD;
      questionnaire to look at bereaved relatives' views about care provided in seven different&#xD;
      countries within Europe and Latin America. In the first part of the project CODE was&#xD;
      translated into the main language of each country. Volunteers and bereaved relatives in each&#xD;
      country were asked to give feedback about whether CODE was easy to understand, sensitive, and&#xD;
      easy to complete. Based on the feedback a common version of CODE that is suitable for use&#xD;
      across all the countries was developed.&#xD;
&#xD;
      In the next phase of the project, relatives who have recently experienced a bereavement where&#xD;
      one of their family members has died from cancer in a hospital, will be invited to complete&#xD;
      the CODE questionnaire about two months after the patient's death. The relatives may complete&#xD;
      CODE on paper, using a computer, or by interview. The aim is to have 100 completed CODE&#xD;
      questionnaires from each of the seven countries. The data from the questionnaires will be&#xD;
      used to make a report on the current quality of care for dying cancer patients in hospitals&#xD;
      across the seven countries. It will also be possible to compare the care between the&#xD;
      countries and identify areas needing improvement.&#xD;
&#xD;
      In the next phase of the project, health care professionals, researchers and bereaved&#xD;
      relatives together will use their knowledge and experience to find effective ways to improve&#xD;
      the weak areas identified, and assess the results of putting these changes into practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ABSTRACT&#xD;
&#xD;
      Background: In order to ensure the highest quality of care is provided for dying patients and&#xD;
      their families, one needs to first be able to robustly evaluate the current quality of care.&#xD;
      One identified method is to assess this from the user-perspective by conducting bereaved&#xD;
      relatives' surveys. 'Care Of the Dying Evaluation' (CODE) is a recognised, validated&#xD;
      post-bereavement questionnaire which has been extensively used within the United Kingdom. The&#xD;
      ERANet-LAC CODE project aims to use CODE in a wider international context. In Work Package 1&#xD;
      of the project, CODE will be translated and pilot tested in volunteers and bereaved relatives&#xD;
      in the partner countries. Using a consensus procedure, a final version of the international&#xD;
      CODE (i-CODE) questionnaire will be developed.&#xD;
&#xD;
      Aims: The present project (Work Package 2) aims to advance the international evidence in care&#xD;
      for dying cancer patients by undertaking an observational study of bereaved relatives' views&#xD;
      across seven participating countries. The overall aims of Work Package 2 (WP2) are to:&#xD;
&#xD;
        -  Conduct an international survey of bereaved relatives of cancer patients dying in&#xD;
           hospitals, using the CODE questionnaire&#xD;
&#xD;
        -  Use the CODE data to provide feedback about the quality of care and level of family&#xD;
           support at an international and national level, allowing for cross-country comparisons&#xD;
&#xD;
        -  Conduct a web survey of all participating institutions to be able to interpret the&#xD;
           survey data in the context of information about each organisation and the level of&#xD;
           specialist palliative care provision at each site / country&#xD;
&#xD;
      Methods: Bereaved adult relatives, to adult cancer patients who had an 'expected' death in&#xD;
      hospital, will be approached face to face, by telephone or in writing and invited to complete&#xD;
      the CODE questionnaire. The CODE questionnaire pack will be sent out 6-8 weeks after&#xD;
      bereavement. CODE may be completed via self-completion paper questionnaire, via on-line&#xD;
      questionnaire, or facilitated via a researcher using a tablet, telephone or face-to-face&#xD;
      interview, according to what is feasible and acceptable in each country. The aim is 100&#xD;
      completed questionnaires per country. Basic demographics will be recorded for all potential&#xD;
      participants and for the patients who died.&#xD;
&#xD;
      Analysis of results: Data will be analysed using SPSS and according to the CODE user guide,&#xD;
      to present a common international report, individual country reports and cross-country&#xD;
      comparisons. Data will be interpreted in the context of knowledge about the individual&#xD;
      sites/countries.&#xD;
&#xD;
      Conclusions: The expected outcomes from WP2 are an international survey and cross-country&#xD;
      comparisons about the current quality of care for dying cancer patients as perceived by&#xD;
      bereaved people, including key areas where care needs to be improved. WP3 of the project will&#xD;
      use the results of the international survey to implement changes to improve the care.&#xD;
&#xD;
      INTRODUCTION&#xD;
&#xD;
      The present project was proposed in response to the ERANet-LAC 2nd Joint Call on Research and&#xD;
      Innovation and approved for funding under the European Commission's 7th framework program.&#xD;
      The aim of the project is to inform and develop an evidence based approach to systematically&#xD;
      standardize assessment and care of dying cancer patients, using relative generated outcomes.&#xD;
      The project will be conducted in four European and three South American countries three years&#xD;
      starting from January 2017. The project contains three Work Packages (parts). This protocol&#xD;
      describes the work to be undertaken in Work Package 2 (CODE International Survey).&#xD;
&#xD;
      BACKGROUND&#xD;
&#xD;
      The delivery of appropriate care for dying cancer patients remains a key medical, social,&#xD;
      economic and political issue. However, the quality of care for the dying is diverse both&#xD;
      within and between EU-LAC countries.&#xD;
&#xD;
      Based on the international evidence base, a set of core principles for care of the dying has&#xD;
      been defined. These principles are applicable to the care of dying cancer patients, as well&#xD;
      as other patients, worldwide.&#xD;
&#xD;
      In order to ensure the highest quality of care provisions, one needs to first be able to&#xD;
      robustly evaluate the current quality of care. One method is to assess this from the&#xD;
      user-perspective by conducting bereaved relatives' surveys.&#xD;
&#xD;
      'Care Of the Dying Evaluation' Questionnaire&#xD;
&#xD;
      One post-bereavement questionnaire is 'Care Of the Dying Evaluation' (CODE). This is a&#xD;
      42-item self-completion questionnaire, developed within the UK, and focused on the quality of&#xD;
      care and the level of support provided to individuals and their families in the last days of&#xD;
      life and the immediate post-bereavement period.&#xD;
&#xD;
      CODE has been used and validated with bereaved relatives, including undertaking cognitive&#xD;
      'think aloud' interviews to assess face and content validity; assessing CODE's stability over&#xD;
      time by conducting test-retest reliability analysis; and assessing the construct validity and&#xD;
      internal consistency of CODE. Subsequently, CODE has been used across hospices, hospitals and&#xD;
      community settings.&#xD;
&#xD;
      In Work Package 1 of the present project, CODE was translated from English into the main&#xD;
      language of each partner country according to established international procedures, and pilot&#xD;
      tested in volunteers and bereaved relatives to assure understanding and appropriate cultural&#xD;
      adaptation. Based on feedback from the testing in each country, a common, international&#xD;
      version of CODE (iCODE) has been established through a consensus procedure.&#xD;
&#xD;
      AIMS &amp; OBJECTIVES&#xD;
&#xD;
      The present project (Work Package 2) aims to advance the international evidence in care for&#xD;
      dying patients by undertaking an observational study of bereaved relatives' views across&#xD;
      seven participating countries, by use of the CODE questionnaire.&#xD;
&#xD;
      The overall aims of Work Package 2 (WP2) are:&#xD;
&#xD;
        -  Conduct an international survey of bereaved relatives of cancer patients dying in&#xD;
           hospitals, using the CODE questionnaire&#xD;
&#xD;
        -  Conduct a web survey of all participating institutions to aid in the interpretation of&#xD;
           the survey data&#xD;
&#xD;
        -  Use the CODE data to provide feedback about the quality of care and level of family&#xD;
           support at an international and national level, allowing for cross-country comparisons&#xD;
&#xD;
      METHODS&#xD;
&#xD;
      Study sites&#xD;
&#xD;
      The necessary number of hospitals caring for adult cancer patients will be recruited as study&#xD;
      sites. The study will only be performed in institutions defined as hospitals&#xD;
&#xD;
      Recruitment&#xD;
&#xD;
      The relative / next-of-kin must be approached after the patient's death. The investigators&#xD;
      will approach the person recorded as next-of-kin in the patient's hospital record.&#xD;
&#xD;
      Only one completed questionnaire will be included per deceased patient.&#xD;
&#xD;
      Recruitment will be done prospectively. The method of recruitment will be adapted as to what&#xD;
      is feasible and in the individual country.&#xD;
&#xD;
      DATA COLLECTION&#xD;
&#xD;
      CODE International Survey&#xD;
&#xD;
      Data to be collected The CODE questionnaire is the common data collection tool of the study.&#xD;
      CODE also includes demographic data. Information about the hospital stay will be included for&#xD;
      all cases, as part of the inclusion procedure.&#xD;
&#xD;
      Method of data collection&#xD;
&#xD;
      The CODE questionnaire will be sent to the participants 6-8 weeks post bereavement, with on&#xD;
      reminder. CODE International Survey was intended as a postal survey, but other data&#xD;
      collection methods will also be accepted.&#xD;
&#xD;
      Sample estimation:&#xD;
&#xD;
      Minimum acceptable number of questionnaires per country is 100 (with this number, a 95%&#xD;
      confidence interval will give a margin of error of +/- 10% of the primary outcome).&#xD;
&#xD;
      Data transfer&#xD;
&#xD;
      The electronic version and database for CODE for each country/language will be developed in&#xD;
      Norway using the Corporate Surveyor software. The databases will be merged in Norway for the&#xD;
      final common analyses.&#xD;
&#xD;
      A web survey of study sites will also be conducted.&#xD;
&#xD;
      DATA ANALYSIS&#xD;
&#xD;
      Data will be analysed using the R statistical package, using descriptive statistics&#xD;
      (proportions (%) for categorical data; means and standard deviations for continuous&#xD;
      parametric data and medians and interquartile range for continuous non-parametric data).&#xD;
&#xD;
      The dataset, anonymised at patient, site and country level, will be aggregated at&#xD;
      international level to enable an international report. Results will be summarised in tabular&#xD;
      and graphical format, as appropriate.&#xD;
&#xD;
      Free text comments will be analysed using qualitative methods (text condensation).&#xD;
&#xD;
      PROJECT MANAGEMENT AND WORK PLAN&#xD;
&#xD;
      All partners have signed the consortium agreement. The PIs are responsible for the CODE&#xD;
      international survey in their respective countries. The group of PIs constitute the project&#xD;
      General Assembly and decision-making body.&#xD;
&#xD;
      WP1 (Preparation and Piloting) ran from month 1 to month 7 of the project, i.e. from January&#xD;
      to August 2017.&#xD;
&#xD;
      WP2 is designed to run from month 8 to month 22 of the project, i.e. from September 2017 to&#xD;
      November 2018.&#xD;
&#xD;
      Time line and deliverables&#xD;
&#xD;
      Confirmation of ethical approval for CODE International Survey in each country: month 6 (July&#xD;
      2017) Web survey of institutions ready for use: month 6 (July 2017) Fully developed, tested&#xD;
      and web-accessible data collection tools: month 6 (July 2017) i-CODE ready for use: month 7&#xD;
      (Aug 2017) Completed web survey of inclusion sites: month 10 (Nov 2017) Completed&#xD;
      international survey with at least 600 completed CODE questionnaires: month 22 (Nov 2018)&#xD;
      Report on CODE International Survey data: month 22 (Nov 2018)&#xD;
&#xD;
      SPONSORSHIP AND BUDGET&#xD;
&#xD;
      Financial support for the project was granted from national research funding agencies in the&#xD;
      participating countries, except in the UK. The University of Liverpool, UK, takes part in the&#xD;
      project as self-financed partner.&#xD;
&#xD;
      No commercial interests are involved in the study. No conflicts of interest have been&#xD;
      declared. Participants receive no financial benefit for participation.&#xD;
&#xD;
      ETHICAL APPROVAL AND GOVERNANCE&#xD;
&#xD;
      The Project Lead (PI) for each country will seek the necessary approvals for CODE&#xD;
      International Survey, from their local/regional ethics committee, and from their&#xD;
      institutional review board as needed. All countries will need ethical approval for WP2.&#xD;
&#xD;
      All potential participants will be given a Participant Information Sheet detailing the aims&#xD;
      of the study and informing that participation is fully voluntary.&#xD;
&#xD;
      PATIENT AND PUBLIC INVOLVEMENT Both volunteers and bereaved relatives will be deeply involved&#xD;
      in developing i-CODE to be used for the international survey.&#xD;
&#xD;
      After the survey has been performed, bereaved relatives will be involved in the action&#xD;
      planning on how to address the main areas of concern identified.&#xD;
&#xD;
      CONFIDENTIALITY AND DATA MANAGEMENT&#xD;
&#xD;
      The Project Lead for each country will preserve the confidentiality of participants taking&#xD;
      part in the study. All data will be anonymised and individual participants will not be&#xD;
      identifiable from published data.&#xD;
&#xD;
      All data will be stored on a secure, password protected research server. Data will be stored&#xD;
      for up to five years after the completion of the project before being confidentially shredded&#xD;
      or deleted.&#xD;
&#xD;
      DISSEMINATION AND PUBLICATIONS&#xD;
&#xD;
      A website for the project will be established.&#xD;
&#xD;
      Authorship will be defined according to the Vancouver Guidelines. National data may be&#xD;
      published by the study group in each country.&#xD;
&#xD;
      The last project meeting with presentations and discussions of the project findings will be&#xD;
      arranged as an open international conference.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 15, 2017</start_date>
  <completion_date type="Actual">December 7, 2018</completion_date>
  <primary_completion_date type="Actual">December 7, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>CODE (Care Of the Dying Evaluation) Questionnaire Item 30 Score for Relatives' Perception of How Much of the Time the Deceased Patient Was Treated With Dignity and Respect, by Nurses, and by Doctors</measure>
    <time_frame>6-8 weeks post bereavement</time_frame>
    <description>CODE (Care Of the Dying Evaluation) questionnaire, item 30: How much of the time was the deceased patient treated with dignity and respect, by nurses, and by doctors.&#xD;
Maximum obtainable score 4, minimum 0. The higher score, the better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CODE (Care Of the Dying Evaluation) Questionnaire Item 31: Whether Relatives Perceived Themselves Adequately Supported in the Patients' Last Days of Life, or Not</measure>
    <time_frame>6-8 weeks post bereavement</time_frame>
    <description>CODE (Care Of the Dying Evaluation) questionnaire, item 31: Were you adequately supported in the patient's last days of life? Yes/no question. The higher percentage of relatives answering 'yes', the better outcome.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Individual Items of CODE (Care Of the Dying Evaluation) Questionnaire.</measure>
    <time_frame>6-8 weeks post bereavement</time_frame>
    <description>Individual questionnaire items of the CODE (Care Of the Dying Evaluation) questionnaire. Maximum value 4, minimum value 0. The higher score, the better outcome.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">914</enrollment>
  <condition>Neoplasms</condition>
  <condition>Bereavement</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>Bereaved relatives</arm_group_label>
    <description>Bereaved relatives after cancer deaths in hospitals</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Next-of-kin to cancer patient who died an expected death in hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Next-of-kin to a patient who died an 'expected' death from cancer in hospital&#xD;
&#xD;
          -  Has been present at the hospital together with the patient at least some of the time&#xD;
             during the patient's last two days. (This might not always be known or recorded,&#xD;
             therefore the participant may have the option to pass the questionnaire on to somebody&#xD;
             better placed to complete it.)&#xD;
&#xD;
          -  Patient was ≥ 18 years of age at the time of Death&#xD;
&#xD;
          -  Patient had been admitted to the hospital (not any specific ward) at least three&#xD;
             calendar days (e.g., admission August 1st, died August 3rd)&#xD;
&#xD;
          -  Able to give written informed consent, which might be implied when the participant&#xD;
             completes and returns the questionnaire, in keeping with the ethical stipulations for&#xD;
             each country&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient had a sudden and unexpected death&#xD;
&#xD;
          -  Unable to complete the questionnaire due to language abilities or reduced cognitive&#xD;
             functioning (in some countries the offer of a translator would be provided if someone&#xD;
             wanted to complete the questionnaire but had difficulty due to languages)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dagny F. Haugen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bergen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Carlos B. Udaondo</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Investigaciones Médicas Alfredo Lanari. Universidad de Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Privado de Córdoba</name>
      <address>
        <city>Córdoba</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sumare State Hospital</name>
      <address>
        <city>São Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katholisches Klinikum Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Centre of the Johannes Gutenberg University of Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <zip>N-5021</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haraldsplass Deaconal Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bærum Hospital, Vestre Viken</name>
      <address>
        <city>Bærum</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Førde Central Hospital</name>
      <address>
        <city>Førde</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haugesund Hospital</name>
      <address>
        <city>Haugesund</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stavanger University Hospital</name>
      <address>
        <city>Stavanger</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pulmonological Hospital in Bydgoszcz</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>D. Wladyslaw Biegański Regional Specialist Hospital</name>
      <address>
        <city>Grudziądz</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>F. Dłutek Autonomic Public Healthcare Centre</name>
      <address>
        <city>Rypin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Provincial Specialist Hospital in name of the blessed priest Popiełuszko</name>
      <address>
        <city>Wloclawek</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Paluckie Health Centre, Żnin Hospital</name>
      <address>
        <city>Żnin</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Liverpool University Hospital</name>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mutualista Asociación Hospital Evangélico</name>
      <address>
        <city>Montevideo</city>
        <country>Uruguay</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Germany</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>Uruguay</country>
  </location_countries>
  <link>
    <url>http://www.icode7.org/icode7/homepage.html</url>
    <description>Project website</description>
  </link>
  <link>
    <url>https://www.eucelac-platform.eu/sites/default/files/short_pdescription_2nd_joint_call_0.pdf</url>
    <description>Short description of project, ERANet-LAC website</description>
  </link>
  <link>
    <url>https://tjinfo.uib.no/Vedlegg?id=f6a7088ae4cec596f566c8c7b1004145</url>
    <description>Innovations Umbrella booklet - a collection of ideas and experiences from the ERANet-LAC CODE project</description>
  </link>
  <reference>
    <citation>The 2015 Quality of Death index. Ranking palliative care across the world. The Economist Intelligence Unit. A report by The Economist Intelligence Unit. Lien Foundation 2015.</citation>
  </reference>
  <reference>
    <citation>Pastrana T, De Lima L, Wenk R, et al. Atlas de Cuidados Paliativos de Latinoamérica. Houston,TX: IAHPC Press, 2012.</citation>
  </reference>
  <reference>
    <citation>Pastrana T, Eisenchlas J, Centeno C, De Lima L. Status of palliative care in Latin America: looking through the Latin America Atlas of Palliative Care. Curr Opin Support Palliat Care. 2013 Dec;7(4):411-6. doi: 10.1097/SPC.0000000000000008. Review.</citation>
    <PMID>24145682</PMID>
  </reference>
  <reference>
    <citation>National care of the dying audit for hospitals, England. National report, Royal College of Physicians, May 2014</citation>
  </reference>
  <reference>
    <citation>The International Collaborative for Best Care for the Dying Person. Supporting Care in the Last Hours or Days of Life. May 2014.</citation>
  </reference>
  <reference>
    <citation>Department of Health (2008). End of life care strategy. Promoting high quality care for all adults at the end of life. Department of Health: London.</citation>
  </reference>
  <reference>
    <citation>Burge F, Lawson B, Johnston G, Asada Y, McIntyre PF, Grunfeld E, Flowerdew G. Bereaved family member perceptions of patient-focused family-centred care during the last 30 days of life using a mortality follow-back survey: does location matter? BMC Palliat Care. 2014 May 14;13:25. doi: 10.1186/1472-684X-13-25. eCollection 2014.</citation>
    <PMID>24855451</PMID>
  </reference>
  <reference>
    <citation>Office of National Statistics (2014). National Survey of Bereaved People (VOICES) 2014. Office of National Statistics.</citation>
  </reference>
  <reference>
    <citation>van der Heide A, de Vogel-Voogt E, Visser AP, van der Rijt CC, van der Maas PJ. Dying at home or in an institution: perspectives of Dutch physicians and bereaved relatives. Support Care Cancer. 2007 Dec;15(12):1413-21. Epub 2007 Apr 20.</citation>
    <PMID>17447086</PMID>
  </reference>
  <reference>
    <citation>Mayland CR, Williams EM, Ellershaw JE. Assessing quality of care for the dying: the development and initial validation of a postal self-completion questionnaire for bereaved relatives. Palliat Med. 2012 Oct;26(7):897-907. Epub 2011 Nov 1.</citation>
    <PMID>22045726</PMID>
  </reference>
  <reference>
    <citation>Department of Health (2013) The NHS Friends and Family Test: Publication Guidelines.</citation>
  </reference>
  <reference>
    <citation>Mayland CR, Williams EM, Addington-Hall J, Cox TF, Ellershaw JE. Does the 'Liverpool Care Pathway' facilitate an improvement in quality of care for dying cancer patients? Br J Cancer. 2013 May 28;108(10):1942-8. doi: 10.1038/bjc.2013.203. Epub 2013 May 16.</citation>
    <PMID>23681186</PMID>
  </reference>
  <reference>
    <citation>Mayland CR, Williams EM, Addington-Hall J, Cox TF, Ellershaw JE. Assessing the quality of care for dying patients from the bereaved relatives' perspective: further validation of &quot;Evaluating care and health outcomes--for the dying&quot;. J Pain Symptom Manage. 2014 Apr;47(4):687-96. doi: 10.1016/j.jpainsymman.2013.05.013. Epub 2013 Nov 5.</citation>
    <PMID>24210451</PMID>
  </reference>
  <reference>
    <citation>Mayland C, Williams E, Ellershaw J. How well do current instruments using bereaved relatives' views evaluate care for dying patients? Palliat Med. 2008 Mar;22(2):133-44. doi: 10.1177/0269216307085742. Review.</citation>
    <PMID>18372378</PMID>
  </reference>
  <reference>
    <citation>Mayland CR, Lees C, Germain A, Jack BA, Cox TF, Mason SR, West A, Ellershaw JE. Caring for those who die at home: the use and validation of 'Care Of the Dying Evaluation' (CODE) with bereaved relatives. BMJ Support Palliat Care. 2014 Jun;4(2):167-174. doi: 10.1136/bmjspcare-2013-000596. Epub 2014 Mar 28.</citation>
    <PMID>24681559</PMID>
  </reference>
  <reference>
    <citation>Mayland C. User-guide for 'Care of the Dying Evaluation' (CODETM). The Marie Curie Palliative Care Institute Liverpool, 2015.</citation>
  </reference>
  <reference>
    <citation>Mayland CR, Mulholland H, Gambles M, Ellershaw J, Stewart K. How well do we currently care for our dying patients in acute hospitals: the views of the bereaved relatives? BMJ Support Palliat Care. 2017 Sep;7(3):316-325. doi: 10.1136/bmjspcare-2014-000810. Epub 2017 Jan 17.</citation>
    <PMID>28096171</PMID>
  </reference>
  <reference>
    <citation>Quality Assurance for Care of the Dying: Cheshire &amp; Merseyside Strategic Clinical Network. Network Report. October 2015.</citation>
  </reference>
  <reference>
    <citation>Stiel S, Heckel M, Bussmann S, Weber M, Ostgathe C. End-of-life care research with bereaved informal caregivers--analysis of recruitment strategy and participation rate from a multi-centre validation study. BMC Palliat Care. 2015 May 2;14:21. doi: 10.1186/s12904-015-0020-4.</citation>
    <PMID>25934560</PMID>
  </reference>
  <reference>
    <citation>Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012 Dec;40(8):795-805. doi: 10.1177/1403494812465030.</citation>
    <PMID>23221918</PMID>
  </reference>
  <reference>
    <citation>Germain A, Mayland CR, Jack BA. The potential therapeutic value for bereaved relatives participating in research: An exploratory study. Palliat Support Care. 2016 Oct;14(5):479-87. doi: 10.1017/S1478951515001194. Epub 2015 Oct 29.</citation>
    <PMID>26510786</PMID>
  </reference>
  <results_reference>
    <citation>Mayland CR, Gerlach C, Sigurdardottir K, Hansen MIT, Leppert W, Stachowiak A, Krajewska M, Garcia-Yanneo E, Tripodoro VA, Goldraij G, Weber M, Zambon L, Passarini JN, Saad IB, Ellershaw J, Haugen DF. Assessing quality of care for the dying from the bereaved relatives' perspective: Using pre-testing survey methods across seven countries to develop an international outcome measure. Palliat Med. 2019 Mar;33(3):357-368. doi: 10.1177/0269216318818299. Epub 2019 Jan 10.</citation>
    <PMID>30628867</PMID>
  </results_reference>
  <results_reference>
    <citation>Hansen MIT, Haugen DF, Sigurdardottir KR, Kvikstad A, Mayland CR, Schaufel MA; ERANet-LAC CODE project group. Factors affecting quality of end-of-life hospital care - a qualitative analysis of free text comments from the i-CODE survey in Norway. BMC Palliat Care. 2020 Jul 7;19(1):98. doi: 10.1186/s12904-020-00609-x.</citation>
    <PMID>32635903</PMID>
  </results_reference>
  <results_reference>
    <citation>Haugen DF, Hufthammer KO, Gerlach C, Sigurdardottir K, Hansen MIT, Ting G, Tripodoro VA, Goldraij G, Yanneo EG, Leppert W, Wolszczak K, Zambon L, Passarini JN, Saad IAB, Weber M, Ellershaw J, Mayland CR; ERANet-LAC CODE Project Group. Good Quality Care for Cancer Patients Dying in Hospitals, but Information Needs Unmet: Bereaved Relatives' Survey within Seven Countries. Oncologist. 2021 Jul;26(7):e1273-e1284. doi: 10.1002/onco.13837. Epub 2021 Jun 17.</citation>
    <PMID>34060705</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>June 12, 2018</study_first_submitted>
  <study_first_submitted_qc>June 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2018</study_first_posted>
  <results_first_submitted>August 3, 2021</results_first_submitted>
  <results_first_submitted_qc>September 30, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 28, 2021</results_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>questionnaire survey</keyword>
  <keyword>care for dying patients</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The plan only includes sharing of data within the consortium.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 15, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/32/NCT03566732/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bereaved Relatives</title>
          <description>Bereaved relatives after cancer deaths in hospitals</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="914">1683 eligible cases identified and screened, 914 participants enrolled.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="914">914 completed questionnaires</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bereaved Relatives</title>
          <description>Bereaved relatives after cancer deaths in hospitals</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="914"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>18-29 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30-39 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40-49 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>50-59 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="241"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60-69 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="208"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>70-79 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>80-89 years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="610"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Argentina</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Norway</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Uruguay</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Poland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brazil</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>United Kingdom</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Type of ward where the patient died</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Medical or surgical ward</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="447"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Palliative care unit</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="231"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oncology ward</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Intensive care unit</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Emergency unit</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="914"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>CODE (Care Of the Dying Evaluation) Questionnaire Item 30 Score for Relatives' Perception of How Much of the Time the Deceased Patient Was Treated With Dignity and Respect, by Nurses, and by Doctors</title>
        <description>CODE (Care Of the Dying Evaluation) questionnaire, item 30: How much of the time was the deceased patient treated with dignity and respect, by nurses, and by doctors.&#xD;
Maximum obtainable score 4, minimum 0. The higher score, the better outcome.</description>
        <time_frame>6-8 weeks post bereavement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bereaved Relatives</title>
            <description>Bereaved relatives after cancer deaths in hospitals</description>
          </group>
        </group_list>
        <measure>
          <title>CODE (Care Of the Dying Evaluation) Questionnaire Item 30 Score for Relatives' Perception of How Much of the Time the Deceased Patient Was Treated With Dignity and Respect, by Nurses, and by Doctors</title>
          <description>CODE (Care Of the Dying Evaluation) questionnaire, item 30: How much of the time was the deceased patient treated with dignity and respect, by nurses, and by doctors.&#xD;
Maximum obtainable score 4, minimum 0. The higher score, the better outcome.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="914"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" lower_limit="3.6" upper_limit="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>CODE (Care Of the Dying Evaluation) Questionnaire Item 31: Whether Relatives Perceived Themselves Adequately Supported in the Patients' Last Days of Life, or Not</title>
        <description>CODE (Care Of the Dying Evaluation) questionnaire, item 31: Were you adequately supported in the patient's last days of life? Yes/no question. The higher percentage of relatives answering 'yes', the better outcome.</description>
        <time_frame>6-8 weeks post bereavement</time_frame>
        <population>Not all participants (bereaved relatives) answered this question. 30 answers missing.</population>
        <group_list>
          <group group_id="O1">
            <title>Bereaved Relatives</title>
            <description>Bereaved relatives after cancer deaths in hospitals</description>
          </group>
        </group_list>
        <measure>
          <title>CODE (Care Of the Dying Evaluation) Questionnaire Item 31: Whether Relatives Perceived Themselves Adequately Supported in the Patients' Last Days of Life, or Not</title>
          <description>CODE (Care Of the Dying Evaluation) questionnaire, item 31: Were you adequately supported in the patient's last days of life? Yes/no question. The higher percentage of relatives answering 'yes', the better outcome.</description>
          <population>Not all participants (bereaved relatives) answered this question. 30 answers missing.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="884"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="788"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Individual Items of CODE (Care Of the Dying Evaluation) Questionnaire.</title>
        <description>Individual questionnaire items of the CODE (Care Of the Dying Evaluation) questionnaire. Maximum value 4, minimum value 0. The higher score, the better outcome.</description>
        <time_frame>6-8 weeks post bereavement</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>One year, during the data collection.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Bereaved Relatives</title>
          <description>Bereaved relatives after cancer deaths in hospitals</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="914"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="914"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="914"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Professor Dagny F. Haugen</name_or_title>
      <organization>University of Bergen</organization>
      <phone>+4747606633</phone>
      <email>dagny.haugen@uib.no</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

